Arkolith/Insider Trading/XLRN/Form 4

Kango Sujay

EVP, Chief Commercial OfficerACCELERON PHARMA INC (XLRN) · full profile →Form 4 · filed Sep 22, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$750K
Net Open-Market Flow
-$750K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 21, 2021Option exercise(M)5K$40.61$203K24K
Sep 21, 2021Sell(S)5K$150.03$750K19K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 21, 2021Option exercise(M)5K—$030K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001179110-21-008894) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML